Latest filing published 02 Jul 2026 for ADC Therapeutics SA. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Ameet Mallik across 3 companies, led by ADC Therapeutics SA, Atara Biotherapeutics, Inc. and Rafael Holdings, Inc. Between 27 May 2021 and 30 June 2026, the trades on record add up to 13 filings.
On the market, this insider has only sold: 1 sale, €124k in total. Outside the open market, there are 11 share grants.
Most recently, on 2 July 2026, the filings show a share grant in ADC Therapeutics SA. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations